Sun Pharma Healthcare Acquisition | M&A Deal

Sun Pharma has acquired a U.S.-based pharmacy business in the United States, for $11.75 billion all-cash. The target operates in the pharmacy sector, supplying healthcare products and services to patients and providers across the U.S. Sun Pharma acquisitions in healthcare M&A are designed to expand pharmaceutical reach and strengthen its U.S. footprint through merger acquisition. This strategic acquisition is structured as a merger acquisition, with Sun Pharma acting as a strategic buyer and the deal announced at over $100M. The all-cash terms support a faster closing path, subject to customary approvals and conditions.